Elsevier

Metabolism

Volume 46, Issue 2, February 1997, Pages 140-145
Metabolism

Insulin secretion, glucose production, and insulin sensitivity in underweight and normal-weight volunteers, and in underweight and normal-weight cancer patients: A Clinical Research Center Study

https://doi.org/10.1016/S0026-0495(97)90291-2Get rights and content

Abstract

Severe malnutrition (< 65% ideal body weight [IBW]) is associated with reduced insulin secretion, decreased receptor affinity, and glucose intolerance. To characterize the abnormality of mild malnutrition in terms of insulin action, both the insulin sensitivity index and insulin secretion were measured in 15 underweight and 15 normal-weight volunteers. Ten patients had localized squamous cell carcinomas of the head and neck, and 20 were normal controls. After a 10-hour overnight fast, all volunteers were studied using Bergman's modified intravenous (IV) glucose tolerance test (IVGTT). Body weight and diagnosis were compared using a 2 × 2 ANOVA. The acute insulin response to IV glucose was reduced in normal-weight and underweight cancer patients by approximately 40% to 50% (P < .05). Both groups of cancer patients had a significantly reduced rate of glucose disposal (1.25 ± 0.29 and 1.27 ± 0.23 %/min) compared with the healthy volunteers (1.82 ± 0.21 and 1.81 ± 0.24 %/min, respectively, P < .05). Glucose production (GP) was significantly increased in the underweight cancer patients versus the weight-matched volunteers (13.9 ± 1.3 v 10.8 ± 0.5 μmol/kg/min, P < .05). Normal-weight and underweight cancer patients had a 32% to 44% reduction in insulin sensitivity (P < .05). In contrast to the effects of cancer, underweight controls had twice the insulin sensitivity compared with normal-weight controls (P < .01). Since insulin secretion decreased in underweight controls, the increased insulin sensitivity may have been due to an increased insulin action and to factors associated with leanness.

References (37)

  • EM Rutanen et al.

    Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: Comparison of endometrial cancer patients with healthy controls

    J Clin Endocrinol Metab

    (1993)
  • RN Bergman et al.

    Physiological evaluation of factors controlling glucose tolerance in man: Measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

    J Clin Invest

    (1981)
  • H Kuzuya

    Determination of free and total insulin and C-peptide in insulin-treated diabetes

    Diabetes

    (1977)
  • WD Odell et al.

    Simplified, partially automated method for radioimmunoassay of human thyroid-stimulating, growth, luteinizing, and follicle-stimulating hormones

    J Lab Clin Med

    (1967)
  • RW Farmer et al.

    Plasma cortisol determination: Radioimmunoassay and competitive binding compared

    Clin Chem

    (1974)
  • RH Unger et al.

    Glucagon antibodies and an immunoassay for glucagon

  • T Anna-Maija et al.

    Radioimmunoassay of tumor necrosis factor in serum

    Clin Chem

    (1987)
  • WA Daughaday et al.

    Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-extracted serum

    J Clin Endocrinol Metab

    (1980)
  • Cited by (34)

    • Effect of body mass index on insulin secretion or sensitivity and diabetes

      2015, American Journal of Preventive Medicine
      Citation Excerpt :

      These associations were observed in both sexes. Previous studies9,19 have demonstrated an association between underweight and a mild reduction in fasting insulin; underweight individuals have lower insulin secretion than people with BMI<23.0. The primary mechanisms contributing to deterioration in insulin secretion are glucose toxicity, genetic variants, and increased cell damage with age.

    • Age differences in the risk of diabetes incidence according to body mass index level in Japanese women: BMI and diabetes in women

      2013, Obesity Research and Clinical Practice
      Citation Excerpt :

      First, there are genetic factors that are associated with diabetes, and some of these genes were found among those with a low BMI [20,21]. Second, being underweight is associated with a mild reduction in fasting insulin and persons with underweight have poorer insulin secretion than persons with normal weight [22,23]. Third, underweight Japanese have a higher body fat percentage compared with underweight Caucasians, and thus lower muscle mass available for metabolizing glucose [24].

    • Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia

      2012, Clinical Nutrition
      Citation Excerpt :

      NSCLC patients receiving the same insulin infusion rates as controls reached a lesser hyperinsulinemia. Weight-losing patients have shown hypoinsulinemic responses to oral glucose,61 IV glucose62 and during the hyperinsulinemic clamp.54,63 In this study, deficient endogenous insulin secretion is unlikely the cause, as C-peptide was suppressed equally.

    • Increased postabsorptive and exercise-induced whole-body glucose production in patients with chronic obstructive pulmonary disease

      2011, Metabolism: Clinical and Experimental
      Citation Excerpt :

      Potential mechanisms underlying decreased insulin sensitivity in these patients include BW [24], the presence of low-grade systemic inflammation [24], and hypoxemia [25]. Regarding the observed duality in insulin sensitivity in underweight and normal-weight COPD patients, it is important to notice that being underweight is also associated with increased insulin sensitivity in healthy subjects [26]; so this is not a unique feature in COPD. However, it is remarkable that insulin sensitivity was increased in underweight patients characterized by elevated levels of circulating catecholamines because it is known that epinephrine induces hyperglycemia and peripheral insulin resistance in vivo [27].

    View all citing articles on Scopus

    Supported in part by Clinical Nutrition Research Unit Young Investigator Award No. CA42710, Clinical Investigator Award No. K08-DK-02083, National Institutes of Health General Clinical Research Center Program No. M01 RR00425, and the American Institute of Cancer Research.

    View full text